Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Biotech
Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3
A year and a half after Sanofi swooped on Johnson & Johnson’s dismantled vaccines unit to pick up an E. coli candidate, the asset failed its trial.
James Waldron
Feb 13, 2025 4:14am
Boehringer's schizophrenia drug fails trio of phase 3 trials
Jan 16, 2025 11:58am
J&J pauses Varipulse US debut following 4 reports of strokes
Jan 8, 2025 3:00pm
Big Pharma layoff rounds jump 281% in 2024
Jan 3, 2025 3:29pm
FDA opens use of J&J's Impella heart pumps to pediatric patients
Dec 12, 2024 2:30pm
Alligator lets loose 70% of staff, sinking stock 53%
Dec 2, 2024 10:40am
